You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
Public Rights-of-Way Assessment Instrumentation to Determine Accessibility
SBC: BENEFICIAL DESIGNS INC Topic: 081FH2City planners and engineers need detailed assessments of public rights-of-way to evaluate existing conditions, determine compliance with draft accessibility guidelines, and plan reconstruction projects. Current assessment methods are inadequate and inefficient due to the time and resources required. This project will develop an automated public rights-of-way assessment process and the measuremen ...
SBIR Phase II 2010 Department of Transportation -
Novel Therapeutic Approach to Acute Lung Injury
SBC: NAVIGEN, INC. Topic: NHLBIDESCRIPTION (provided by applicant): In our Phase 1 application, we described an endothelial specific receptor, Robo4, that is expressed in mature vessels and is upregulated following endothelial injury. Robo4, following activation by its protein ligand, Slit2, reduces agonist induced vascular leak in vitro and in vivo. We provided evidence of Slit2's efficacy in animal models of acute lung injury ...
SBIR Phase II 2010 Department of Health and Human Services -
Blink Prosthesis for Facial Paralysis Patients
SBC: Ripple, LLC Topic: N/ADESCRIPTION (provided by applicant): The goal of this program is to create an implantable stimulator device to restore functional eye blink in patients with unilateral facial nerve paralysis. The system will electrically stimulate the paretic eyelid when EMG electrodes detect normal blink from the contralateral eye to produce a synchronous blink. The implant will consist of a thin, ceramic package ...
SBIR Phase II 2009 Department of Health and Human Services -
Anti-HTRA1 Therapy For AMD
SBC: NAVIGEN, INC. Topic: N/ADESCRIPTION (provided by applicant): In our Phase I application, we proposed that blocking HTRA1 with antibodies might be an effective strategy for treating age related macular degeneration. We tested this hypothesis by a) generating monoclonal antibodies against HTRA1 and b) determining whether a monoclonal antibody would be effective in models of vascular eye disease. We have accomplished each o ...
SBIR Phase II 2009 Department of Health and Human Services -
Real-Time Heteroplasmy Analysis on Microarrays
SBC: PHILOTEK, LLC Topic: N/ADESCRIPTION (provided by applicant): Many human diseases-if not all human diseases-and human health appear to be linked to our genetics. Major government and private research efforts are focused on investigating this linkage. Unfortunately, one of our best tools for this critical work-i.e., microarrays-holds us back, as most provide only generally qualitative results, limiting their usefulness. O ...
SBIR Phase II 2009 Department of Health and Human Services -
Venous Window Access Catheter For Hemodialysis
SBC: VITAL ACCESS, INC. Topic: N/ADESCRIPTION (provided by applicant): A novel, venous window access device (VWAD), anastomotic tool, and minimally invasive, image-guided surgical procedure to provide hemodialysis for patients suffering from End Stage Renal Disease (ESRD) have undergone early stage development. The device can serve as a destination therapy or as a bridge device to provide temporary access during maturation of an ...
SBIR Phase II 2009 Department of Health and Human Services -
PHASE II TOPIC 233: AUTOMATED PROCESSING OF CANCER-RELATED DATA
SBC: QUANTUMMARK LLC Topic: N/ALocation 1860 WENDY WAY RENO, NV 89509 United States N44CO200900040 $749 996.00 2 009 PHASE II TOPIC 233: AUTOMATED PROCESSING OF CANCER-RELATED DATA Department of Health and Human Services SBIR PHS2009-1 QUANTUMMARK LLC Phase II N44CO200900040 1 ...
SBIR Phase II 2009 Department of Health and Human Services -
Non-Invasive Drug Delivery to Treat Severe Uveitis
SBC: ACIONT, INC. Topic: N/ADESCRIPTION (provided by applicant): The overarching aim of this innovative proposal is to develop and then commercialize a non-invasive topical product which is safe and easy to administer that treats severe uveitis, including intermediate and posterior uveitis. Uveitis is the third leading cause of blindness in the United States. Heretofore, the primary treatments of intermediate and posterior u ...
SBIR Phase II 2009 Department of Health and Human Services